Vitamin K₂ therapy for postmenopausal osteoporosis.
- 2014-05-16
- Review
- Nutrients 6(5)
- Jun Iwamoto
- PubMed: 24841104
- DOI: 10.3390/nu6051971
- Moderate evidence
- Rigorous Journal
- Clinical
combined alendronate and menatetrenone therapy enhanced the decrease in serum ucOC concentrations and further increased femoral neck BMD
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes